VALUE: Analysis of results [1]

Lancet

Volumn 364, Issue 9438, 2004, Pages 931-935

  Staessen, Jan A ^a   Thijs, Lutgarde ^a   Birkenhäger, Willem H ^b   Williams, Simon G ^c   Barker, Diane ^d   Schlosshan, Dominik ^d   Tan, Lip Bun ^d   Scheen, André J ^e   Sever, Peter ^f   Kario, Kazuomi ^g   Pickering, Thomas ^h   Fretheim, Atle ⁱ   Julius, Stevo ^j   Weber, Michael A ^j  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b 3076 DP   (Netherlands)

^c LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g JICHI MEDICAL UNIVERSITY   (Japan)

^h NY ^*  (United States)

ⁱ N   (Norway)

^j UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; VALSARTAN; CALCIUM CHANNEL BLOCKING AGENT; DRUG DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LETTER; MODEL; PRIORITY JOURNAL; STROKE; AGED; BLOOD PRESSURE; DRUG EFFECT; MIDDLE AGED; NOTE; PATHOPHYSIOLOGY;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION; MIDDLE AGED; TETRAZOLES; VALINE;

EID: 4444382845     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17010-4     Document Type: Letter

References (5)

1. S Julius SE Kjeldsen M Weber Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Lancet 363 2004 2022 2031
2. MA Weber S Julius SE Kjeldsen Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial Lancet 363 2004 2049 2051
3. SS Franklin MG Larson SA Khan Does the relation of blood pressure to coronary heart disease change with aging? The Framingham Heart Study Circulation 103 2001 1245 1249
4. JA Staessen JG Wang L Thijs Cardiovascular prevention and blood pressure reduction: a meta-analysis Lancet 358 2001 1305 1315
5. JA Staessen R Fagard L Thijs Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension Lancet 350 1997 757 764